Innovative ETFs Channel A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark By Max ChenJune 30, 2021
Modern Alpha Channel The BioRevolution: An ETF That Taps Into Nearly Everything By Max ChenJune 21, 2021
Equity ETF Channel Play the Technology Side of Healthcare with the IHI ETF By Ben HernandezApril 13, 2021
Leveraged & Inverse Channel Biden’s Infrastructure Can Put These 2 Leveraged Funds in Play By Ben HernandezApril 9, 2021
Innovative ETFs Channel Greater Regulatory Scrutiny Could Weigh on Biotech ETFs By Max ChenMarch 24, 2021
Thematic Investing Channel Healthcare. China. This Global X ETF Combines Two Potent Sectors By Ben HernandezMarch 3, 2021
Innovative ETFs Channel Illumina Earnings, Forward Guidance Strengthen Biotech ETFs By Max ChenFebruary 12, 2021
Innovative ETFs Channel Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug By Max ChenJanuary 29, 2021
Innovative ETFs Channel Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Disruptive Technology Channel Bad Ideas: The Industries on Innovation’s Chopping Block By Max ChenNovember 17, 2020
Innovative ETFs Channel 5 Reasons Why Investors Should Consider a Healthcare ETF By Max ChenNovember 3, 2020
Webcasts America’s ‘Financial First Responders’ Examine the 2020 Election By Max ChenOctober 21, 2020